PTPRD/PTPRT mutations as potential positive predictor for response of immune checkpoint inhibitors in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Zeng, Jian
Wang, Guoqiang
Yan, Zhengqing
Zheng, Hao
Li, Jianqiang
Tao, Feng
机构：
[1] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
[3] Wen Zhou Med Univ, Lishui Peoples Hosp, Dept Resp Med, Affiliated Hosp 6, Lishui, Peoples R China
[4] Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China
[5] Jiaxing Univ, Dept Resp Med, Affiliated Hosp, Jiaxing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15112
引用
收藏
页数：2
相关论文
共 50 条
  • [31] WNT pathway mutations (APC/CTNNB1) and immune checkpoint inhibitors (ICI) response in metastatic non-small cell lung cancer (NSCLC) patients
    Ros Montana, F. J.
    Iranzo, P.
    Pedrola, A.
    Callejo, A.
    Pardo, N.
    Amat, R.
    Carbonell, C.
    Martinez, A.
    Navarro, A.
    Cedres, S.
    Dienstmann, R.
    Palmer, H. G.
    Vivancos, A.
    Felip, E.
    ANNALS OF ONCOLOGY, 2019, 30 : 799 - 799
  • [32] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
    Qiu, Zhenbin
    Chen, Zihao
    Zhang, Chao
    Zhong, Wenzhao
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [33] Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer
    Bote, Helena
    Mesas, Andres
    Baena, Javier
    Herrera, Mercedes
    Paz-Ares, Luis
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (03) : 289 - 300
  • [34] Immune Checkpoint Inhibitors in Oncogenic Driven Non-small Cell Lung Cancer
    Fonseca, A.
    Silva, E.
    Coutinho, D.
    Campainha, S.
    Dias, M.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S339 - S340
  • [35] Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Soh, Junichi
    Hamada, Akira
    Fujino, Toshio
    Mitsudomi, Tetsuya
    CANCERS, 2021, 13 (16)
  • [36] Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Ushio, Ryota
    Murakami, Shuji
    Saito, Haruhiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [37] Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Jung, Chi Young
    Antonia, Scott J.
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2018, 81 (01) : 29 - 41
  • [38] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Lin, Gen
    Wang, Zhijie
    Chu, Qian
    Hu, Yi
    Huang, Dingzhi
    Wang, Jun
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Yutao, Liu
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    THORACIC CANCER, 2024, 15 (05) : 419 - 426
  • [39] Chronological Effects of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Guo, Xinyue
    Qin, Lanqun
    Wang, Xinmeng
    Geng, Qian
    Li, Dongqing
    Lu, Yingying
    Jiang, Hua
    IMMUNOLOGY, 2025, 174 (04) : 402 - 410
  • [40] The role of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Pistamaltzian, Nikolaos F.
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 435 - 447
12345